MedPath

Minimally Invasive Flap With Platelet Rich Fibrin or Growth Factor Enhanced Matrix in Treatment of Intrabony Defect

Phase 2
Completed
Conditions
Periodontal Regeneration
Interventions
Procedure: Minimal invasive flap technique
Combination Product: minimally invasive flap with root contioning by EDTA and growth factor enhanced matrix GEM21S
Procedure: Minimally invasive flap with root conditioning (EDTA) and platelet rich fibrin
Registration Number
NCT04786327
Lead Sponsor
Tanta University
Brief Summary

Twenty-one intra-bony defects in fifteen systemically healthy patients with moderate to severe chronic periodontitis were randomly classified into 3 groups, 7 sites each. Group І treated by MIST alone, group ІІ treated by MIST + ethylenediamine-tetraaceticacid (EDTA) + PRF and group III treated by MIST + EDTA + GEM 21S. The clinical parameters including probing pocket depth (PPD), clinical attachment level (CAL) and bleeding on probing (BOP), were recorded at baseline, 3, 6 and 9 months post-surgery. Cone beam computed tomography (CBCT) was performed at baseline and 9 months post-surgery to evaluate bone level and bone density

Detailed Description

: Twenty-one intra-bony defects in fifteen systemically healthy patients with moderate to severe chronic periodontitis were randomly classified into 3 groups, 7 sites each. Group І treated by MIST alone, group ІІ treated by MIST + ethylenediamine-tetraaceticacid (EDTA) + PRF and group III treated by MIST + EDTA + GEM 21S. The clinical parameters including probing pocket depth (PPD), clinical attachment level (CAL) and bleeding on probing (BOP), were recorded at baseline, 3, 6 and 9 months post-surgery. Cone beam computed tomography (CBCT) was performed at baseline and 9 months post-surgery to evaluate bone level and bone density.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria

• Presence of at least one tooth with PPD and CAL loss of ≥ 5 mm associated with an intra-bony defect of ≥ 2 mm according to Cortellini and Tonetti, 2007

Read More
Exclusion Criteria
  • Patients with uncontrolled or poorly controlled diabetes, life-threatening conditions, or requiring antibiotic prophylaxis were excluded.
  • Smokers
  • Pregnant patients.
  • Patients with aggressive periodontitis.
  • Patients with multiple interconnected vertical defect walls.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
treated by using Minimally invasive flap only.Minimal invasive flap technique7 sites treated with Minimally invasive flap only
MIST with root conditioning (EDTA) and GEM 21S .minimally invasive flap with root contioning by EDTA and growth factor enhanced matrix GEM21S7 sites treated with Minimally invasive flap plus EDTA root conditioning and application of growth factor enhanced matrix GEM21S
Minimally invasive flap with root conditioning (EDTA) and platelet rich fibrin .Minimally invasive flap with root conditioning (EDTA) and platelet rich fibrin7 sites treated with Minimally invasive flap plus EDTA root conditioning and application of platelet rich fibrin graft
Primary Outcome Measures
NameTimeMethod
the change bleeding on probing score9 months

the change in bleeding on probing measured at baseline,3,6 and 9 months evaluation period

the change Clinical attachment level9 months

the change in Clinical attachment level measured at baseline, 3,6 and 9 months using the periodontal probe

Cone beam radiograph9 months

Cone beam radiograph for measuring the change in area of the defect, depth of the depth and bone density at baseline, 3, 6 and 9 month post operative treatment using OnDemand software of cone beam

the change in probing pocket depth9 months

the change in probing pocket depth was measured at baseline, 3,6 and 9 months evaluation period using periodontal probe

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Malak Mohamed Shoukheba

🇪🇬

Tanta, Egypt

© Copyright 2025. All Rights Reserved by MedPath